Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Clinical trial NCT02947347 · COMPLETED
Trial details
- NCT number
- NCT02947347
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-23
- Primary completion
- 2024-02-21
- Enrollment
- 445
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.